Antibacterial efficacy of R-type pyocins towards Pseudomonas aeruginosa in a murine peritonitis model

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 5, 2008, Pages 1647-1652

  Scholl, Dean ^a   Martin Jr , David W ^a  

^a AvidBiotics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL MEMBRANE; BACTERIAL PERITONITIS; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BLOOD SAMPLING; COLONY FORMING UNIT; CONTROLLED STUDY; DOSE RESPONSE; DRUG PURIFICATION; FEMALE; LETHAL DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPLEEN; TREATMENT RESPONSE;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MICE; PERITONITIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PYOCINS;

EID: 42949089753     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01479-07     Document Type: Article

References (36)

1. Aronoff, S. C., M. M. Olson, M. W. Gauderer, M. R. Jacobs, J. L. Blumer, and R. J. Izant. 1987. Pseudomonas aeruginosa as a primary pathogen in children with bacterial peritonitis. J. Pediatr. Surg. 22:861-864.
2. Barekzi, N. A., K. A. Poelstra, A. G. Felts, I. A. Rojas, J. B. Slunt, and D. W. Grainger. 1999. Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa peritonitis in a murine model. Antimicrob. Agents Chemother. 43:1609-1615.
3. Bernardini J., F. Bender, T. Florio, J. Sloand, L. Palmmontalbano, L. Fried, and B. Piraino. 2005. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J. Am. Soc. Nephrol. 16:539-545.
4. Coetzee, H. L., H. C. De Klerk, J. N. Coetzee, and J. A. Smit. 1968. Bacteriophage-tail-like particles associated with intra-species killing of Proteus vulgaris. J. Gen. Virol. 2:29-36.
5. Dabrowska, K., K. Switała-Jelen, A. Opolski, B. Weber-Dabrowska, and A. Gorski. 2005. Bacteriophage penetration in vertebrates. J. Appl. Microbiol. 98:7-13.
6. Haas, H., T. Sacks, and N. Saltz. 1974. Protective Effect of pyocin against lethal Pseudomonas aeruginosa infections in mice. J. Infect. Dis. 129:470-172.
7. Hagens, S., A. Habel, U. von Ahsen, A. von Gabain, and U. Blasi. 2004. Therapy of experimental Pseudomonas infections with a nonreplicating genetically modified phage. Antimicrob. Agents Chemother. 48:3817-3822.
8. Iijima, M. 1978. Mode of action of pyocin R1. J. Biochem. (Tokyo) 83:395-402.
9. Ishii, S., Y. Nishi, and F. Egami. 1965. The fine structure of a pyocin. J. Mol. Biol. 13:428-431.
10. Ito, S., M. Kageyama, and F. Egami. 1970. Isolation and characterization of pyocins from several strains of Pseudomonas aeruginosa. J. Gen. Appl. Microbiol. 16:205-214.
11. Jacob, F. 1954. Biosynthèse induite et mode d'action d'une pyocin, antibiotique de Pseudomonas pyocyanea. Ann. Inst. Pasteur 86:149-160.
12. Johnson, C. C., J. Baldessarre, and M. E. Levison. 1997. Peritonitis: update on pathophysiology, clinical manifestations, and management. Clin. Infect. Dis. 24:1035-1047.
13. Juergensen, P. H., F. O. Finkelstein, R. Brennan, S. Santacroce, and M. J. Ahern. 1988. Pseudomonas peritonitis associated with continuous ambulatory peritoneal dialysis: a six-year study. Am. J. Kidney Dis. 11:413-417.
14. Kageyama, M., and F. Egam. 1962. On the purification and some properties of a pyocin, a bacteriocin produced by Pseudomonas aeruginosa. Life Sci. 9:471-476.
15. Kageyama M. 1964. Studies of a pyocin. I. Physical and chemical properties. J. Biochem. 55:49-53.
16. Kageyama, M., K. Ikeda, and F. Egami. 1964. Studies of a pyocin. III. Biological properties of the pyocin. J. Biochem. 55:59-64.
17. Kageyama, M. 1975. Bacteriocins and bacteriophages in Pseudomonas aeruginosa, p. 291-305. In T. Mitsuhashi and H. Hashimoto (ed.), Microbial drug resistance. University of Tokyo Press, Tokyo, Japan.
18. Krothapalli, R., W. B. Duffy, C. Lacke, W. Payne, H. Patel, V. Perez, and H. O. Senekjian. 1982. Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis. Arch. Intern. Med. 142:1862-1863.
19. Merrikin, D. J., and C. S. Terry. 1972. Use of pyocin 78-C2 in the treatment of Pseudomonas aeruginosa infection in mice. Appl. Microbiol. 23:164-165.
20. Merril, C. R., B. Biswas, R. Carlton, N. C. Jensen, G. J. Creed, S. Zullo, and S. Adhya. 1996. Long-circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. USA 93:3188-3192.
21. Michéa-Hamzehpour, M., R. Auckenthaler, P. Regamey, and J.-C. Pechère. 1987. Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis. Antimicrob. Agents Chemother. 31:1803-1808.
22. Nakayama, K., K. Takashima, H. Ishihara, T. Shinomiya, M. Kageyama, S. Kanaya, M. Ohnishi, T. Murata, H. Mori, and T. Hayashi. 2000. The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage. Mol. Microbiol. 38:213-231.
23. Shimizu, Y., T. Kamazaki, and S. I. Ishii. 1982. Specific cleavage at fibers of a bacteriophage-tail-like bacteriocin, pyocin R1, by successive treatment with organomercurial compounds and trypsin. J. Virol. 44:692-695.
24. Shinomiya, T., S. Shiga, and M. Kageyama. 1983. Genetic determinant of pyocin R2 in Pseudomonas aeruginosa PAO. I. Localization of the pyocin R2 gene cluster between the trpCD and trpE genes. Mol. Gen. Genet. 189:375-381.
25. Shinomiya, T., S. Shiga, A. Kikuchi, and M. Kageyama. 1983. Genetic determinant of pyocin R2 in Pseudomonas aeruginosa PAO. II. Physical characterization of pyocin R2 genes using R-prime plasmids constructed from R68.45. Mol. Gen. Genet. 189:382-389.
26. Stickler, M., N. Rochanayon, O. J. Razo, J. Mucha, W. Gebel, N. Faravashi, R. Chin, S. Holmes, and F. A. Harding. 2004. An in vitro human cell-based assay to rank the relative immunogenicity of proteins. Toxicol. Sci. 77:280-289.
27. Strauch, E., H. Kaspar, C. Schaudinn, P. Dersch, K. Madela, C. Gewinner, S. Hertwig, J. O. Wecke, and B. Appel. 2001. Characterization of enterocoliticin, a phage tail-like bacteriocin, and its effect on pathogenic Yersinia enterocolitica strains. Appl. Environ. Microbiol. 67:5634-5642.
28. Takeya, K., Y. Minamishima, Y. Ohnishi, and K. Amako. 1969. Rod-shaped pyocin 28. J. Gen. Virol. 4:145-149.
29. Talbot, G. H., J. Bradley, J. E. Edwards, D. Gilbert, M. Scheld, and J. G. Bartlett. 2006. Bad bugs need drugs: an update on the development pipeline from the antimicrobial availability. Clin. Infect. Dis. 42:657-668.
30. Thompson, N. E., and P. A. Pattee. 1981. Genetic transformation in Staphylococcus aureus: demonstration of a competence-conferring factor of bacteriophage origin in bacteriophage 80a lysates. J. Bacteriol. 148:294-300.
31. Uratani, Y., and T. Hoshino. 1984. Pyocin R1 inhibits active transport in Pseudomonas aeruginosa and depolarizes membrane potential. J. Bacteriol. 157:632-636.
32. Wang, J., B. Hu, M. Xu, Q. Yan, S. Liu, X. Zhu, Z. Sun, E. Reed, L. Ding, J. Gong, Q. Q. Li, and J. Hu. 2006. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa. Int. J. Mol. Med. 17:309-317.
33. Watanabe, R., T. Matsumoto, G. Sano, Y. Ishii, K. Tateda, Y. Sumiyama, J. Uchiyama, S. Sakurai, S. Matsuzaki, S. Imai, and K. Yamaguchi. 2007. Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob. Agents Chemother. 51:446-452.
34. Weinstein, W. M., A. B. Onderdonk, J. G. Bartlett, and S. L. Gorbach. 1974. Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect. Immun. 10:1250-1255.
35. Yellin, A. E., P. N. Heseltine, T. V. Berne, M. D. Appleman, M. A. Gill, C. E. Riggio, and F. C. Chenella. 1985. The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis. Surg. Gynecol. Obstet. 161:303-307.
36. Zink, R., M. J. Loessner, and S. Schere. 1995. Characterization of cryptic prophages (monocins) in Listeria and sequence analysis of a holin/endolysin gene. Microbiology 141:2577-2584.